Professional Documents
Culture Documents
Nurse 20110729 162321 daTuR
Nurse 20110729 162321 daTuR
Health
Promotion
Prevention
Treatment
Rehabilitation
- 1
- 0
1.
2. 2-3 (
)
3. 2-3
4.
5.
6.
7.
8.
9.
( )
10.
11.
12. 1-2
(1 = 1 120 45 )
0-4
5-8
9-12
> 80 > 90
The
Metabolic syndrome
> 130/85
10
10
10
20
20
15
15
...
-
-
-
-
-
-
?
:
: 100
: ( 100) -10%
( 100) + 3-5 .
: 105
.
()
165
166
167
168
169
170
171
172
173
174
55.9
59.5
64.1
54.5
58.6
63.2
56.5
60.1
64.8
55.1
59.2
63.8
57.1
60.7
65.6
55.7
59.8
64.4
57.7
61.4
66.4
56.4
60.5
65.0
58.6
62.3
67.5
57.3
61.4
65.9
59.5
63.2
68.6
58.2
62.2
66.8
60.1
63.8
69.2
58.8
62.8
67.4
60.7
64.4
69.8
59.4
63.4
68.0
61.4
65.0
70.5
60.0
64.1
68.6
62.3
65.9
71.4
60.9
65.0
69.8
(Source : Metropolitan Life Insurance Company)
(BMI)
BMI
=
()2
80 150
150
= 1.5 2 = 1.5 x 1.5 = 2.25
80 .
2.25
BMI = 35.56
BMI
BMI
BMI
< 18.5
< 18.5
18.5 - 24.9
18.5 22.9
25.0 - 29.9
23 24.9
30.0 - 34.9
25 29.9
35.0 - 39.9
30 39.9
> 40
> 40
15-25
1 .
30
35
30
35
40
35
40
45-50
1,800-2000 /
1,500-1600 /
1,000-1200 /
2,200-2,500 /
1,800-2000 /
1,200-1500 /
&
&
&
(kcal )
CHO
( )
Prot
( )
Fat
( )
475
81.46
18.29
8.44
(kcal )
CHO
( )
Prot
( )
Fat
( )
462
75.52
20.58
8.62
...
, ?
: 10 %
3 5 /
: 2,000
...
3 :
3 :
3 : ()
!
1 280 cal
30
1 500 cal
1 .
1 .
40
300 cal
20
4 /,
,>"#$%&
4
,<
+
= +
=
= =,.),9)
+
(.))
,4
!?
(<
+
)
/
(.))
/ A
(!)
((
)
A+
(<
<)
(<
<)
2
3
1
,<
,
4 ,.)
+
= +
!
/8/
(948(:!"
; 1 /
!
+
,) (5 ".)
/!
0
(
/ 2 #!
3"
4 ,5
1.5
1.5
2
1
2
3
2
3
80
35
10
70
120
45
20
.)A8
"9"#$%&
480
210
60
280
120
180
80
218
241
19.5
1.9
24
12.3
(.)
85.5
14.9
(.)
150
61
(.)
154
48
(.)
1.2
0.47
()
()
6-8
10
6-8
6-8
6-8
10
6-8
1-2
12
6-8
7-8
6-8
1
()
()
15
80
12
90 150
5
15
25
60
15
3-5
1/2 120 ..
1/2
()
1/2
= 55 70
< 55
,
15 20 %
1 2 35 100
- ,
-
-
- ,,
3-5
3, ,
* Omega 3
Omega 3
| 1- 4 / 100
| 2-3 / 100
| 0.5-2 / 100
:
:
8/ A
1 !
1 25
1.8
0.6
2.2
4.0
3.7
4.9
13.6
5.8
3.2
3.8
36.8
3.4
5.3
24
1.96
1.3
21.2
1.7
27.3
2.3
3.89
5.5
21.4
2.35
5.0
6.1
3
3 /
,,,,
- 2 3
-
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Ryttig 1990
A,!"
A,!",B)"
CD
A8
$&A,4
A2:. *
!,09$&" ,<
- ," &8$ #!:
$&%:&# 0
+8, 48 !#C
#8,<4
$&F0 G G
* A.)2:. A(
CD
"&48)AA8
!
"#$%%&' (#)
* (,
% - ")
( "(- %/( (%.) 2543
1.
2.
3.
4.
5.
6.
7.
8.
% &'(
! "#
!% &
216
1,500
540
12,000
200
1,500
200
360
69,000
13,320
45,960
585,984
43,200
13,320
7,644
74,040
5,372.78
5,605.00
7,947.00
278,137.00
10,508.50
4,992.80
4,992.80
19,678.00
Chronic Kidney Disease (CKD)
1.
9"/:
H)A/#8##8
( 3,84+
A9
1.1 9, 48" & Creatinine(Cr.) + P# >1.2 ./8 .
+ < >1.4 ./8 .
1.2 9R!!= (Urinalysis) ,4#W$)" :
)$)DR!!= > 30./8 .
> 300 ./
#"#W$)DR!!=,.A 5#"<)
A)&/#8#
,.
2%#!%
% 6
(Peritoneal
dialysis)
I2%% 35-50 K2
L
2/..
6
6K
6
35-50 K2L
2/
..
25-30 K2L
2/..
35 K2L
2/..
40-50 K2L
2/..
35-50 K2L
2/
..
2%#!%%
6
(Peritoneal dialysis)
6
2-3 2K/
1.5-3 2K/
$
500 M.M. +
KO H
0.75-1.5 2K/
$
500 M.M. +
KO H
3-4 /
"#
$%
"1
2$
(Hemodialysis)
1.5-3 /
0.6-1.2 / $
12-15K22K /
2%#!%%
6
(Peritoneal dialysis)
2-3 /
0.8-1.2 / $
12-15 K22K/
1-2 /
1-1.4 /
''38 8 1
: (>2,+) (%&'(&' ?61@6A16B 4& A8.DB G
& )
FD H F1'91B&3('FD)
'.' 60 D
*
F1'91BD' = 0.8 8'.' 1 D
*
D'
F1' 0.8 x 60 = 48 8'
'.' 60 D
*
F1'91BD' = 1.1-1.2 8'.' 1 D
*
D'
F1' 1.1 x 60 = 66-72 8'
-33-C'3D
O
. L8.
($))
,4 !?(7)
20
30
35
40
50 60
1 1/2(10.5) 2 1/2(17.5) 3 (21) 4(28) 5 (35) 6 (42)
(>(2)
3 (6)
/(1)
3 (3)
/ A
(0.5) 1 (0.5)
20
2 (1) 2 (1)
30
50
35
40
60
-33-C'3D
O
. L8.
(
F1')
50
55
60
65
70
80
,4
!?(7)
(7)
(>(2)
(2
/(1)
3 (3)
3 (3)
4 (4)
2 (1) 2(1)
2 (1) 2 (1)
2 (1)
/ A
(0.5)
(0.5)
51
54.5
2 (1)
60
63.5
70.5
80.5
-.*8
E*'(8'5.P8 D'
& -FK '*-*G' '
E*'91BCL&FQ6G&3
R'6L83CL&FQ6-8*G6
&3E*'.5.&E16E5'-8*G'EBFK' 85.&
DOG*& '*13
S'D
'(8'5.P8 FT'
'1(
' 8DB )
A+ 1 !D
45 #$ (& )
1
- , 1
1 -
1
-
1
- !" 2
= 12
' -FK ' 3'*
60
48
40
240 D
*-*1
192 D
*-*1
160 D
*-*1
D
(D
70 (& )
%&'(&' 1 (20 )
=
& 1 9EE1
-FK ' (L (&'A1B6
4&
F1'
$) ,B )
70
25
70
1/2
70
8/ A
1 !
/ A
1 ! = 0.5 $), 40-80 #$ (& )
3-4 :
1 :
4-5 :
3 :
$[,8)
,4)"
A) "
. L8
&
&&
&.'16 1
A16
7 D**D
(
&(% 1 9EE1)
' 3
. L8'(2 '(23; 'F*9G*
25 D**D
'(29G*E 13 1F* S8' .6 FL 60 D**D
88 (1 `
'*)
60 D**D
. L8C* &
. L8
'
2 D**D
- D**D
44 D**D
(//)
(//)
(/)
(/)
(/)
1.2-1.5
35-50
3,000- 4,000
K
0.8-1.2 /
1-1.4 /
,
,,,,
,,,,
( )
( )
( )
( kcal )
( )
100
( 3 )
10.7
1.1
0.2
52
13
10.9
0.68
0.12
47.45
6.5
,:9A++
=8"&8
&8"
(systolic)D9")"
(# #,.)
-+
,!(=
#
<120
<80
=8".),=!
,#!:
120-139
80-89
"b#
C(.?
!:(
>140
>90
"b#
"D<
"b#
+
(=
&8 8 =W
(# #,.)
5-22 /
8 10
#$
8
BMI #
"=.(8<
A+,,#/,/ A
8-14
,A+
98$[,8) = 2,400 2-8
# #/=, 4 1 <
<
=30 .)
4-9
8, 4,,&5
2-4
1.
45
@ ,,,
@ ,,,,
@
@
,
() ,
1.
11 %
2.
18 %
3.
71 %
,2549
()
(/)
(/)
9-12
400-1175
350-1100
13-15
500-1,500
400-1250
16-18
525-1,600
425-1275
19-30
500-1475
400-1200
31-70
475-1450
400-1200
>71
400-1200
350-1050
50-200
125-350
KSM"
$%T%L2HU
2$ 1 #.#
= M 2,000 .
62 1 #.#
= M 465-600 .
MKX Y 1 #.
= M 960-1,420 .
MHY$[ 1 #.#
= M 55 .
M% 1#.#
= M 140 \ 160.
6K6
! 1 #.#
= M 67 - 76 .
%# 1 ##
= M 492 .
%1 1 ##
= M 339 .
H]%U 60 = M 1,500 .
^]%U 42 = M 1,000 .
SKSM"
NACL 1 Na 390 mg
Les-S0
1 Na 150 mg
61.5 %
,&4,.ai
#
+
=A&
=,
+#
=,.)
(DASH DIET)
7-8
()
4-5
()
4-5
4-5
()
4-6
(8-12 )
1
()
28 , 16-18 , 20-24
, 45-47 10-12
1-2
1,000
,,,
,,
,,
()
,,
,,
,,
,,,
, ,
?
/
-
-
-
-,
-
-
-
-
-
.....
,, ,
3-4
( , )
1-2
2-3
> 25 3
1.
2. ,
3.
4. 25-30 /
5.
...
-
-
-
-
-
-
-
-
-
-
-
-
-
5
1
10
2
2
1.
2.
3.
4. 2
5. 4
6.
7.
,<= &:
! #,& 4A!
( =,9)
84
1 <. 4 "=.
..))&?$"Ah,8!: ,< +R" 4+R
84,&484D! i ,<
4
8
), ).))A+!: ,< .8
/ "=.
84.))!&"2
,< .(.?
.)D
&)! ,4<D
( =8:8[,5
9=A8
/.)!08 9D
4#5A8
(
D==(9,\
D
, 5 (,
A
&D
,\==, ,=9=)RP = ,< )
# () ( =! ( ="=""
.,8# ,< .D
8 8 ,"4 & 4A!
,9)A8
(+5
() SHA
1
2
3
4
5
2
?
-
-
-
, , ,
,
25-35 /
7 /
- 20 /
- 10 /
200 /
50-60 /
15 /
20-30 /
-
10-12
-
2
-
2 ()
- 0%
2-3
- ///
6
-
3-5
-
2-4
- 6-8
- Saturated fat < 7%
- Cholesterol < 300 mg/day
- Trans Fat
< 1%
(plaque)
LDL-
2
HDL-
LDL-
HDL-
HDL- 1 ./
2 %
(SFA)
,
1 .
1 .
1 .
1 .
2 .
(PUFA)
( HDL-C) (LDL-C)
,,,
1
1 .
1 .
1 .
1 .
(MUFA) (LDL-C)
1 .
10
6
SFA (gm)
MUFA (gm)
PUFA(gm)
WHO*
< 28.6
28.6-42.8
< 28.6
12
78
10
14
77
18
45
37
13
20
62
16
24
60
12
21
67
50
39
10
,,
1
4-5
10
=
=
=
=
45
45
45
45
6
2
, , ,
,,
.!D
,\.)) CW=, !2 A /!D
,+
!:A8
$8
A#8+8 $8)&0W&!( = &"2
,\.)98D
(/:
H
.))RPA!2"=..A8
(=""
8:8[
!# ,<
- /:
H8!# A:
!
- /:
H .))P
R . &( = 8
- /:
H .)),"4 "=..A8
- /:
H .)(.?
"0%=$%<D
8+)
D
==, !
- ,
- ,,
- Lactose
intolerance
2. (Blenderized formula)
5
3. (Commercial formula)
/
1.2 1.5 : 1
Nutrition Composition
Normal dilution (Kcal/ml)
1cal /1cc.
mOsm/kg H2O
355
38
Protein
15
Carbohydrate
55
Fat
30
Source
Protein
(nutrient)
(macro-minerals) micro-minerals
trace minerals 1,6,C
88-100
100
80
74
80
54
Blendera
Nutren
Optimum
Gen DM
DM / Hight Cholesterol
Neo Mune
/ 25%
Pan Enteral
/ COPD (Short
term)
Aminoleban Oral
Isocal
CA / / CVA
Nutren Fibre
/ CVA / /
Nutren Balance
DM / Hight Cholesterol / /
COPD
Peptamen
Nuro / /
(Short term) / low.Alb.
10
Ensure
/ /
Malnutrition
Flow Process
HACCP
//
5
1) BD (1:1) 100 C.
2) BD (1:1)
100 C.C
3) BD (1:1) Sterile 30 C.C
4) BD (1:1) Drip
5) BD (1.2:1)
E.coli, Salmonella
Spp., Glostridium Spp., Staph
aureus, K.lebsiella Spp.
Bacillus cerius
10 (101CFU/ml)
1
1
3
6
%
1-2
5
7.5
10
%
>2
>5
>7.5
>10
, (, )
,
/
/
physical exam:
subcutaneous fat, muscle wasting
$&
=,5
&D<
9.) 8 / / 9$%<""8.(.?
(".)/3
,#=!#.F#%DC8
!)( =,&)""8
368,725
$&D9
319,690
8&
D<
8/8D9( = 8
, 48
8(.[
4&0(.),#89$&
(.[
.)
,+
"C,\/:
HD
8408B)8#!0 #4D<
,"<#8
"=. <= $&(.[
$&
&D<
9.) 8 /
(".)/3
/ 9$%<""8.(.?
$&A
646,345
<= &9,\D
A
94,500
8D<
&8$ #!:
142,625
"8,95",B)"
246,785
8D<
( =>(.[
,< 4 D9
<D
/:
H]r,5( = 8==, D
D<
,!#.(.? [)
&D<
9!:
(Acute or
Trauma
conditions)
[/:
HA8
".!D
/ aC%=.0$%<+/:
HD=,.aA.
$"
3
)%=.0$%<
2532
33%
2532
$" +(
94-98%
2538
68%
2538
55%
2549
50%
2550
54%
#A8
1D 4
#AA8
,
# A8
1D4
A8
".(.?,!#
<50%
A8
".(.?,!#,)
25%
& L* ESPEN 2009 CL&FQ6 75,000 6 E63* 967-.85' 36 FG9i
6000
5000
4000
3000
2000
1000
=,5
=""
=!.
( =!
D9( =
8, 48
D9D,85
1958
3868
1039
5860
542
1967
2182
4095
1038
6429
671
52
2048
2356
4243
1125
6808
420
53
1772
2142
3883
958
5976
473
,"
A,4
==i
50
1902
51
+
: 9/:
H9,<!2## $" !+ &#.? W .) 22/12/53
50-53
16000
17,000
16,382
18000
15,204
15,169
14000
12000
10000
8000
6000
4000
737(4.4%)
346 (2.2% )
2000
780(5.1% )
776(4.5% )
50
51
52
53
+
: 9/:
H9,<!2## $" !+ &#.? W .) 22/12/53
Target
State
KSK_IH
.
50
I. 50
`.
50
.
51
.I 51
1,550
1,476
1,452
1,287
1,249
1,323
1,353
1,489
22$
769
716
826
801
504
276
647
842
558
659
516
459
360
490
417
318
Y
434
290
262
231
284
73
276
455
44
95
65
46
53
187
49
50
!%!
127
143
169
167
167
46
166
77
^
203
168
122
201
115
82
78
73
T%T
1013
1,134
898
985
831
967
995
961
62
18
13
44
236
327
33
37
679
543
501
592
544
580
548
651
5,439
5,242
4,824
4,813
4,343
4,351
4,562
4,953
2T!
2
22
.
51 . 51
I.
51
&
+/:
" /
- /:
H 0,!)A8
" #8=,#%=
$%<
=,85&0W%.)!&P
- /:
HA8
" &8 =,#%=$%<
- /:
HA8
" $%<""8.),)( = 8%,4)+
"<)
- /:
H( =P#A8
" &:8
$%<( =$%<""8,4D
)
b#.)=!&?
+
8.#<<)
- t"#D$"
- Referred $8!2".(.?( =$%<.)
,)+
908,
&?
- 0,
/:
H( =P#
- !"!0C+(.?$8D<
$%<""8
<)
8
-/:
H 0,!)A8
" #8=,#%=
$%< > 80 %
.".*
1.98.$&D<
(""=,#SGA
2.98.t Nutritional Assessment
3.,+
.)!!+#<<) *
4.$& z#8 / 8:( /:
H.))&
,B={ *
5. ="#8/:
H 9D
&(=8
$%<""8*
6. 98#9!,!#&:
", )b#
"#$%&/:
H P#( =/:
!D9*
7.98.!4!##?+
: &:
8
$%<( =$%<
""8
8.<.#8!4!,+
2+
: &:
!
/:
H( =P#D
A8
"&:
Study
Purpose:
- /:
HA8
" .))&0W& 2: $%<( =$%<""8
t!"/:
HD$" ,4!"!0
C ( =&0W%<)#.)8)
- /:
H( =P#A8
" &:8
$%<( =$%<""8,4D
)
b#.)=!&?
20=!&?
- /:
HA8
" $%<""8.),)( = 8%
,4)+
"<)
DO
Plan
="
- 8( =.".t Nutritional Assessment
- 8( =.".D<
Screening tool .),=!
- 8="8:( %=.0$%</:
H IPD
Act
-
-
-
-
- D/C
IPD
Nutrition Screening
Mild malnutrition
- Objective Date
-
-
-
Laboratory
- ,
(Nutritional Assessment)
-
-
()
- Calorie Intake
2-3
- Objective Date
-
: D/C
D/C 1 3
D/C
D/C
P#"
4i ...............
2./ Albumin 4Total Lymphocyte Count (TLC)(D8)
2.1 / Albumin
2.2 / TLC
< 1,000 cells/ mm3 (3)
< 2.5 g/dl ( 3 )
2.6-2.9 g/dl ( 2 )
1,000-1,200 cells/ mm3 (2)
3.0-3.5 g/dl ( 1)
1,201-1,500 cells/ mm3 (1)
> 3.5 g/dl
> 1,500 cells/ mm3
3. :+/:
H
/ (2 )
/ (1 )
(1)
&,8#
4. , )( +
D< 4 !8?
8 // (2 )
,#+
/
+
(1)
A."
&,8#
5.
5.1 <#8
i (2 ) , (2)
0# (1 ) ,4#(0)
5.2 #W.)# #
( 2 ) #
(1)
# (1) #,.# (0)
6. ,4 > 2 !8?
6.1 RP,&)
/ 4 ! (2)
4 " (2)
4A8
# (0)
6.2 RP="".,8#
.
,!)(2)
8.
(2) #
(0)
6.3 RP#
,9) (2)
& 4A!
(2) #
(0)
7. &!2D,& 4A
#8,) (2)
)/:
< (1) ii ( 0) # (0)
/ &8%=$%<,"4
&=(....................&=(
0 9 &=(( SGA= A : Mild malnutrition ) A"&,!),#8%=.0$%<
10 1 5&=( (SGA = B : Moderate malnutrition )"&,!),#8%=.0$%<=,#%=$%<%D3
16 &=( ( SGA = C : Severe malnutrition ) "&,!),#8%=.0$%< =,#%=$%<%D 24 <.
$8, 4$&4
t.),\:
Cancer
CKD Critically ill (#b#) Liver disease COPD Stroke
DM
.) a..!0? $&#.? %&#<0a!? $" F#"8)
#. #8
PCT
NS
-
-
-
-
-CA
TR
-
-
-
-
1,2 /./ . /
. /NICU/PICU
-
-
- Obesity
- CA
- ,
F11
- CAPD
- Per-Dialysis
1 ,2
.
.
-
-
-
-
-TPN
OPD
-
-Cholesterol
OPD CKD
- CAPD
- Per-Dialysis
CA /
53- 54
-
-
-CA
MU
Gastrostomy
-CKD
Prot 40 gm/d
1
Low
Bacteria
- Low Bacteria /
BD..
TR
.. - CKD
/
1 3 6 -12
/ 1
..
MU
-
-
CAPD
MU
..! CA
1-2
Low K ..OK
..
!0(""=,#/ $&
98"D
(/:
H CAPD ( =/:
8:( ,4 "$%<D/:
H$&A CAPD"
9
.
8
9.)
D<
=,#
.)!08/5
/4
/3
23
23
12
23
23
11
23
23
4. G6G*915B S&5'D
. G(
23
5. (X'91BD . G(
+
=,#
,B )
97
4.2
12
103
4.5
16
108
4.7
23
11
92
4.0
23
23
16
97
4.2
23
23
11
100
4.3
23
22
14
99
4.5
23
23
17
109
4.7
/2
.)!08/1
A=,#
..
)+
988
$%<
$%<
&"&0D
<#8
,9
.)
`#"#D
.,
.# /:
H , )
=<0( =#9&W=G ,\
$%<.)`#"#$8
0,)Job =9
% ,;>=( =
=,#%=$%<D 0
,!)A&"& 0
A,\.)!!+#<<)
,49)%=
.A. ,\
.)!!+#<<)
,9
.)+8&
=+8.C=
$%<
":
.0$&
.)
D<
$%<""8
,9
.)/ #A
2:
&!
(.?( =F#!%
/:
H
!4! 0W?( =
!2.)A,=!
$%<
L!%G#K#L2
G#
TS[,
TST
TSbc`,
TSH
TST#
H#-aK%,[2H
TS %$
,[2#-aK%,
TSI`K
TSa
T#-aK%
TSIIK[
Dietitian
Pharmacist
Physiotherapy
Behavioral
Exercise
Specialists
/:
H
#)&!0+... ,4!0+%.)8)
"#LI
G#
2%
...